Product Images Valsartan

This is the description of a medicine named Valsartan. The tablets are film-coated and each tablet contains 160 mg of Valsartan. The usual dosage details are available on the package insert. The medicine should be stored at a controlled room temperature and protected from moisture. The drugs should be kept out of the reach of children. The batch coding details are mentioned for a specific area. The medicine is manufactured by Hetero Labs Limited, India, for Camber Pharmaceuticals, NJ, USA. For patient information, one can visit the website of histochempharma.com/medication-guides.*

This text describes a medication called Valsartan, Tablets, USP. Each film-coated tablet contains 320 mg of Valsartan, USP. It is a prescription drug and the usual dosage is mentioned in the package insert. It needs to be stored at a controlled room temperature of 20 to 25 degrees Celsius to protect from moisture. It is manufactured by Hetero for Camber Pharmaceuticals under a license number. Patients should keep this and all drugs out of reach of children. Patent information is available and a US contact number is provided.*

NDC 31722-154-32 is a pack of Valsartan Tablets, USP containing 100 (10 x 10) unit-dose tablets. The film-coated tablets each contain 320mg USP Valsartan. They can only be used with a prescription, and usual dosages are indicated in the package insert. They should be stored at a temperature between 20° and 25°C and protected from moisture. The pack is childproof, and patient information is available on the Camber Pharmaceuticals website. The pack includes a manufacturing licence number and indicates that the tablets are produced by Helaro Labs Limited in India.*

This is a description of medication for Valsartan, a tablet that contains 40mg of USP. The dosage is to be taken as per the details mentioned in the package insert. The medication should be stored at a controlled room temperature and protected from moisture. It should be dispensed in a tight container and kept out of children's reach. The manufacturer is Camber Pharmaceuticals, Inc., Piscataway, NJ 08854. Further information on this medication is available on camberpharma.com.*

This is a medication called Valsartan Tablets, USP with the strength of 40mg. The usual dosage is stated in the package insert. The medication comes in 100 unit dose tablets and each tablet is film-coated. Tris unk-dose package is not acid-resistant. It should be stored at 20° to 25°C and protected from moisture. The manufacturer is Camber Pharmaceuticals, Inc. The patent information is available on the website. If you need any information, you can contact at 1-866-4951995.*

This is a description of a medication called Valsartan, available in the form of film-coated tablets, containing 80mg of Valsartan each, and dispensed in a tight container. It is meant for adults only and should be stored at temperatures between 20°C to 25°C. The package insert should be consulted for information on the usual dosage. Patient information is available by contacting the manufacturer. The medication should be protected from moisture and kept out of reach of children. The text also includes details about the manufacturing company and its location, as well as a license number.*

This is a drug information sheet for Valsartan Tablets, USP, containing 80 mg of Valsartan per tablet. It includes the usual dosage, storage instructions, and warnings about keeping it away from children. The unit-dose package is not child-resistant. The page also includes the NDC code, contact information for the manufacturer, and the drug's license number. The initial text is not readable and seems to be an error.*

This appears to be a table displaying various Subgroups of Patients and the percentage of individuals in these subgroups who favor either Valsartan or Captopril as medications. The subgroups are divided based on age (<65 or >65), gender (male or female), ethnicity (Caucasian or Non-Caucasian), region (US or Non-US), and usage of Beta-blockers. Valsartan is favored by 70.4% of all patients while Captopril is favored by 29.6% of all patients.*